Boston Scientific (BSX) Price & Analysis

Compare

3,486 Followers

BSX Stock Chart & Stats

Day’s Range― - ―

52-Week Range$80.64 - $108.94

Previous CloseN/A

Volume5.49M

Average Volume (3M)6.56M

Market Cap

$158.98B

Enterprise Value$172.04B

Total Cash (Recent Filing)$725.00M

Total Debt (Recent Filing)$11.71B

Price to Earnings (P/E)63.9

Beta0.79

Next Earnings

Oct 22, 2025

EPS Estimate

0.72

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.75

Shares Outstanding1,481,751,600

10 Day Avg. Volume6,050,493

30 Day Avg. Volume6,560,317

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.08

Enterprise Value/Revenue9.80

Enterprise Value/Gross Profit15.85

Enterprise Value/Ebitda41.37

Forecast

1Y Price Target

$125.60

Price Target Upside17.07% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering20

Bulls Say, Bears Say

Bulls Say

EarningsBoston Scientific reported Q2 revenue and EPS ahead of expectations due to strong performance in PFA and Watchman products.

Growth OutlookBoston Scientific raised its 2025 organic growth guidance to 14-15%, which is higher than previous estimates.

Product InnovationThe label expansion for Watchman to include the option to use Intracardiac Echocardiography (ICE) can materially speed up the procedure as it removes the need for general anesthesia.

Bears Say

Market ImpactManagement anticipates an impact on Interventional Cardiology due to the neo2 discontinuation.

Product AdvisoryBoston Scientific issued a physician advisory letter highlighting calcification risk in older-generation ePTFE-coated ENDOTAK RELIANCE defibrillation leads.

Boston Scientific News

Medtronic Stock (MDT) Slides Despite Corporate Re-Jig to Boost Ailing Valuation

Shares in medical technology group Medtronic ($MDT) lost ground today after a corporate reshuffle aimed at boosting M&A....

17d ago

BSX

MDT

Boston Scientific Announces Executive Retirement Plan Update

Boston Scientific ( ($BSX) ) has shared an announcement. On August 29, 2025, Boston Scientific announced that Jeffrey...

2d ago

BSX

Buy Rating for Boston Scientific Amid Manageable Risks in ENDOTAK RELIANCE Leads

TD Cowen analyst Josh Jennings maintained a Buy rating on Boston Scientific today and set a price target...

1M ago

BSX

Boston Scientific price target raised to $118 at Oppenheimer (July 24)

Oppenheimer on July 24 raised the firm’s price target on Boston Scientific (BSX) to $118 from $110 and...

1M ago

BSX

Insider Moves: Charles Schwab, Phillips 66, NXP, Corning, Boston Scientific

Insiders have been trading these 5 stocks: (($SCHW)), (($PSX)), (($NXPI)), (($GLW)) and (($BSX)). Here is a breakdown of...

1M ago

BSX

GLW

Edwards Lifesciences price target raised to $81 from $75 at Canaccord

Canaccord analyst William Plovanic raised the firm’s price target on Edwards Lifesciences (EW) to $81 from $75 and...

1M ago

BSX

Positive Outlook for Boston Scientific Driven by Strong Growth Strategy and Leadership in Key Segments

Analyst Mike Kratky of Leerink Partners reiterated a Buy rating on Boston Scientific, boosting the price target to...

1M ago

BSX

Boston Scientific price target raised to $125 from $120 at RBC Capital

RBC Capital raised the firm’s price target on Boston Scientific (BSX) to $125 from $120 and keeps an...

1M ago

BSX

Boston Scientific price target raised to $118 from $110 at Oppenheimer

Oppenheimer analyst Steven Lichtman raised the firm’s price target on Boston Scientific (BSX) to $118 from $110 and...

1M ago

BSX

Boston Scientific price target raised to $125 from $120 at Truist

Truist analyst Richard Newitter raised the firm’s price target on Boston Scientific (BSX) to $125 from $120 and...

1M ago

BSX

Boston Scientific price target raised to $123 from $117 at Baird

Baird raised the firm’s price target on Boston Scientific (BSX) to $123 from $117 and keeps an Outperform...

1M ago

BSX

Boston Scientific price target raised to $135 from $130 at UBS

UBS raised the firm’s price target on Boston Scientific (BSX) to $135 from $130 and keeps a Buy...

1M ago

BSX

Boston Scientific price target raised to $124 from $118 at Wells Fargo

Wells Fargo analyst Larry Biegelsen raised the firm’s price target on Boston Scientific (BSX) to $124 from $118...

1M ago

BSX

Boston Scientific price target raised to $133 from $125 at Barclays

Barclays raised the firm’s price target on Boston Scientific (BSX) to $133 from $125 and keeps an Overweight...

1M ago

BSX

BSX FAQ

What was Boston Scientific’s price range in the past 12 months?

Boston Scientific lowest stock price was $80.64 and its highest was $108.94 in the past 12 months.

What is Boston Scientific’s market cap?

Boston Scientific’s market cap is $158.98B.

When is Boston Scientific’s upcoming earnings report date?

Boston Scientific’s upcoming earnings report date is Oct 22, 2025 which is in 46 days.

How were Boston Scientific’s earnings last quarter?

Boston Scientific released its earnings results on Jul 23, 2025. The company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.725 by $0.025.

Is Boston Scientific overvalued?

According to Wall Street analysts Boston Scientific’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Boston Scientific pay dividends?

Boston Scientific does not currently pay dividends.

What is Boston Scientific’s EPS estimate?

Boston Scientific’s EPS estimate is 0.72.

How many shares outstanding does Boston Scientific have?

Boston Scientific has 1,481,751,600 shares outstanding.

What happened to Boston Scientific’s price movement after its last earnings report?

Boston Scientific reported an EPS of $0.75 in its last earnings report, beating expectations of $0.725. Following the earnings report the stock price went up 4.459%.

Which hedge fund is a major shareholder of Boston Scientific?

Currently, no hedge funds are holding shares in BSX

Boston Scientific Stock Smart Score

Outperform

Fundamentals

Return on Equity

11.71%

Trailing 12-Months

Asset Growth

11.99%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Boston Scientific

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and markets a wide range of medical devices. Founded in 1979 and headquartered in Marlborough, Massachusetts, the company operates in various sectors including cardiovascular, rhythm management, endoscopy, urology, and neuromodulation. Boston Scientific's core products include stents, catheters, pacemakers, and other innovative devices designed to improve patient outcomes and enhance the quality of life.

Boston Scientific (BSX) Earnings & Revenues

Historic Earnings Reports

BSX Company Deck

BSX Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflected a strong quarter for Boston Scientific, with significant growth across key segments such as Cardiovascular, Electrophysiology, and Asia Pacific regions. Noteworthy achievements in product launches and strategic acquisitions further bolstered the company's positive outlook. However, challenges such as the discontinuation of the ACURATE valve and tariff impacts were notable lowlights. Overall, the highlights significantly outweighed the lowlights.View all BSX earnings summaries

BSX Revenue Breakdown

64.22% Cardiovascular

35.79% MedSurg

BSX Stock 12 Month Forecast

Average Price Target

$125.60

▲(17.07% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"74":"$74","141":"$141","90.75":"$90.8","107.5":"$107.5","124.25":"$124.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":140,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$140.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":125.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$125.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":115,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$115.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[74,90.75,107.5,124.25,141],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,105.41,108.07076923076923,110.73153846153846,113.3923076923077,116.05307692307692,118.71384615384615,121.37461538461538,124.03538461538461,126.69615384615385,129.35692307692307,132.0176923076923,134.67846153846153,137.33923076923077,{"y":140,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,105.41,106.96307692307693,108.51615384615384,110.06923076923077,111.62230769230769,113.17538461538462,114.72846153846153,116.28153846153846,117.83461538461538,119.3876923076923,120.94076923076922,122.49384615384615,124.04692307692306,{"y":125.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,105.41,106.14769230769231,106.88538461538461,107.62307692307692,108.36076923076922,109.09846153846154,109.83615384615385,110.57384615384615,111.31153846153846,112.04923076923077,112.78692307692307,113.52461538461539,114.26230769230769,{"y":115,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":75.16,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.79,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.14,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.62,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.43,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 59,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.32,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":103.79,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":103.19,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.17,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.78,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.41,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >